2,832,000 Shares in Bath & Body Works, Inc. (NYSE:BBWI) Bought by D1 Capital Partners L.P.

D1 Capital Partners L.P. purchased a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 2,832,000 shares of the company's stock, valued at approximately $109,797,000. Bath & Body Works accounts for about 1.8% of D1 Capital Partners L.P.'s holdings, making the stock its 20th biggest holding. D1 Capital Partners L.P. owned 1.31% of Bath & Body Works as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. Norges Bank bought a new stake in Bath & Body Works during the fourth quarter valued at about $73,572,000. Arrowstreet Capital Limited Partnership lifted its position in shares of Bath & Body Works by 79.1% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 3,882,047 shares of the company's stock worth $150,507,000 after buying an additional 1,715,096 shares in the last quarter. Alliancebernstein L.P. grew its holdings in shares of Bath & Body Works by 35.6% in the fourth quarter. Alliancebernstein L.P. now owns 5,178,447 shares of the company's stock valued at $200,768,000 after purchasing an additional 1,360,264 shares in the last quarter. Anomaly Capital Management LP increased its holdings in shares of Bath & Body Works by 38.3% in the 4th quarter. Anomaly Capital Management LP now owns 4,860,876 shares of the company's stock worth $188,456,000 after buying an additional 1,346,752 shares during the last quarter. Finally, Champlain Investment Partners LLC purchased a new stake in Bath & Body Works during the fourth quarter valued at approximately $37,853,000. 95.14% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently commented on BBWI shares. JPMorgan Chase & Co. dropped their price target on shares of Bath & Body Works from $47.00 to $41.00 and set an "overweight" rating for the company in a research note on Monday, April 14th. Barclays cut their price target on Bath & Body Works from $43.00 to $38.00 and set an "equal weight" rating on the stock in a research note on Monday, March 3rd. Raymond James reduced their price objective on shares of Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating for the company in a research note on Thursday, April 17th. Cowen restated a "buy" rating on shares of Bath & Body Works in a report on Thursday, February 27th. Finally, The Goldman Sachs Group reduced their target price on Bath & Body Works from $49.00 to $42.00 and set a "buy" rating on the stock in a research report on Tuesday, April 22nd. Four equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $42.69.

Bath & Body Works Trading Down 0.5 %

Bath & Body Works stock traded down $0.14 during mid-day trading on Friday, hitting $29.61. The company had a trading volume of 3,024,953 shares, compared to its average volume of 4,790,661. The company has a market capitalization of $6.34 billion, a price-to-earnings ratio of 7.22, a P/E/G ratio of 0.92 and a beta of 1.69. Bath & Body Works, Inc. has a 12-month low of $24.96 and a 12-month high of $52.99. The company's fifty day moving average is $31.33 and its 200-day moving average is $33.84.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.04 by $0.05. The firm had revenue of $2.79 billion for the quarter, compared to the consensus estimate of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. As a group, sell-side analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.70%. The ex-dividend date of this dividend was Friday, February 21st. Bath & Body Works's dividend payout ratio (DPR) is presently 21.98%.

Bath & Body Works declared that its board has authorized a share repurchase program on Thursday, February 27th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to reacquire up to 6.4% of its shares through open market purchases. Shares repurchase programs are often a sign that the company's management believes its stock is undervalued.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.